| Jordan William Talan, MD | |
|
330 Brookline Ave, Boston, MA 02215-5400 | |
| (617) 667-7000 | |
| Not Available |
| Full Name | Jordan William Talan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 330 Brookline Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619324407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 297653 (New York) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 297653 (New York) | Primary |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
The first prospective study of ethnic differences in the symptoms of autism in toddlers shows that children from a minority background have more delayed language, communication and gross motor skills than Caucasian children with the disorder. Researchers at the Kennedy Krieger Institute concluded that subtle developmental delays may be going unaddressed in minority toddlers until more severe symptoms develop.
Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.
A landmark study from the Institute of Medicine (IOM) reports that your chance of developing epilepsy at some point in your life is one in 26. Onset is highest in children and older adults. But epilepsy knows no boundaries—it can strike at any age and across all socio-economic levels and ethnicities. There is no known cure and one-third of people with epilepsy have treatment-resistant or refractory epilepsy.
For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent.
CBD Expo Tour 2019, produced by MACE Media Group, one of the nation's largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan William Talan, MD 330 Brookline Ave, Boston, MA 02215-5400 Ph: (617) 667-7000 | Jordan William Talan, MD 330 Brookline Ave, Boston, MA 02215-5400 Ph: (617) 667-7000 |
News Archive
The first prospective study of ethnic differences in the symptoms of autism in toddlers shows that children from a minority background have more delayed language, communication and gross motor skills than Caucasian children with the disorder. Researchers at the Kennedy Krieger Institute concluded that subtle developmental delays may be going unaddressed in minority toddlers until more severe symptoms develop.
Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.
A landmark study from the Institute of Medicine (IOM) reports that your chance of developing epilepsy at some point in your life is one in 26. Onset is highest in children and older adults. But epilepsy knows no boundaries—it can strike at any age and across all socio-economic levels and ethnicities. There is no known cure and one-third of people with epilepsy have treatment-resistant or refractory epilepsy.
For about 90 percent of men with prostate cancer, the cancer remains localized to the primary site, resulting in a five-year survival rate of almost 100 percent.
CBD Expo Tour 2019, produced by MACE Media Group, one of the nation's largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.
› Verified 9 days ago
Kaitlyn My-tu Lam, MBBS Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |